Navigation Links
San Diego Based CRO Signs Agreement With UK Based Spinal Device Manufacturer
Date:3/16/2010

SAN DIEGO, March 16 /PRNewswire/ -- SpineMark CRO Management, a wholly-owned subsidiary of San Diego based SpineMark Corporation, recently signed an agreement with Ranier Technology, a Cambridge, England based spinal medical device manufacturer, to provide contract research support services for the Ranier CAdisc™-L clinical trial, a 3rd generation lumbar total disc replacement device for treatment of degenerative disc disease in the lumbar spine.  SpineMark CRO Management provides site recruitment including utilization of principal investigators from its network of sites, reimbursement strategy development, payor education, trial management, site training, patient recruitment, data management, monitoring, regulatory advice and general oversight to allow Ranier to effectively complete their FDA requirements for approval of new spinal devices.  

"The SpineMark CRO model provides intermediary third party oversight to ensure that the highest quality of monitoring, management and resources can be brought to bear for Ranier, as well as the patients and physicians participating in this trial," explains Marcy Rogers, President and CEO of SpineMark.

The CAdisc™-L design, materials and biomechanics represent a significant clinical advance in the treatment of degenerative disc disease in the lumbar spine.  

"I am delighted to be working with SpineMark. Their specialized dedication to clinical research in spine, their relationships, and their ability to manage various aspects of the US clinical trial process makes them a perfect fit for our study," explains Dr. Geoffrey Andrews, CEO of Ranier Technology.

SpineMark offers an international medical advisory board and access to SpineMark's network of leading physicians and surgeons across the country. The corporation is an expert in FDA regulations and protocol, offering site operations support and training, contract negotiation and financial management, regulatory and compliance oversight and marketing and media relations.  

For more information on SpineMark CRO Management visit www.spinemarkCRO.com

For more information on Ranier Technology Limited visit www.ranier.co.uk

SOURCE SpineMark Corporation

Back to top

RELATED LINKS
http://www.spinemark.com
http://www.spinemarkCRO.com
http://www.ranier.co.uk/

'/>"/>

SOURCE SpineMark Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Tezampanel, TorreyPines Therapeutics Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego
2. PG500 Series Presented at the AACR Annual Meeting in San Diego
3. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
4. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the BIOCOM Investor Conference in San Diego on October 27, 2009
5. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of Zerenex (ferric citrate) for the Treatment of Hyperphosphatemia at the Upcoming American Society of Nephrology Renal Week Meeting in San Diego
6. Phase 2 Data From Oral NKTR-118 Presented at American College of Gastroenterology in San Diego
7. Internationally Renowned Bariatric and Laparoscopic Surgeons To Meet in San Diego
8. Solos Endoscopy, Inc. Receives Purchase Orders from University of California, San Diego Medical Center for its MammoView(TM) Product Line
9. California American Water Celebrates No Drugs Down the Drain Week in San Diego
10. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
11. ActiveSight and CHDI Leverage Fragment-Based Lead Discovery for Huntington Disease Therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... , Dec. 6, 2016 In this age ... to be hopeful.  A special kind of sunglasses, from ... anxious life. Photo - http://photos.prnewswire.com/prnh/20161205/445444 ... Robert Buck, the psychotherapist who developed and patented the ... to overcoming anxiety and worry.  "Anxiety doesn,t have ...
(Date:12/5/2016)... , Dec. 5 2016 United ... Summary GlobalData,s new report, "United Kingdom ... key market data on the United Kingdom Ophthalmic ... millions of US dollars, volume (in units) and ... Coherence Tomography (OCT), Retinal Ultrasound Imaging Systems, Corneal ...
(Date:12/5/2016)...   Mallinckrodt Pharmaceuticals (NYSE: MNK ... that it received a perfect score of 100 percent ... benchmarking survey and report on corporate policies and practices ... equality, administered by the Human Rights Campaign (HRC) Foundation. ... which also earned top marks this year. ...
Breaking Medicine Technology:
(Date:12/6/2016)... ... December 06, 2016 , ... ... released the much-anticipated HydroFX for Water®. This first-of-its-kind water-soluble powder supplement has ... the world’s most powerful antioxidants, molecular hydrogen, HydroFX for Water transforms every ...
(Date:12/6/2016)... ... December 06, 2016 , ... TopConsumerReviews.com recently gave a best-in-class 5 ... , Mobility Scooters give freedom to people who need help getting around. For some, ... facing a long period of rehabilitation after an illness or accident. There is a ...
(Date:12/5/2016)... ... 05, 2016 , ... "FCPX Overlay Glare is a tool that utilizes light ... rendering or complicated compositing," said Christina Austin - CEO of Pixel Film Studios. ... of lights that simulates the look of a glare. Just drag and drop ...
(Date:12/5/2016)... , ... December 05, 2016 ... ... security executive networking and relationship-marketing firm, announced today that nominations will be ... Information Security Executive® (ISE®) Central Awards. , Awards include the Information Security ...
(Date:12/5/2016)... Isles Beach, Fla (PRWEB) , ... December 05, ... ... E. Herman as Keynote speaker for the 21st Annual International Congress on Hematologic ... making the announcement, PER® president, Phil Talamo said, “We are honored to have ...
Breaking Medicine News(10 mins):